BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30527457)

  • 1. Characterization of Metastatic Sternal Lesions on Dynamic Contrast-Enhanced Breast MRI in Women with Invasive Breast Cancer.
    Lee AY; Navarro R; Busby LP; Greenwood HI; Bucknor MD; Ray KM; Joe BN
    Acad Radiol; 2019 Oct; 26(10):1358-1362. PubMed ID: 30527457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and Clinical Significance of Sternal Lesions on Breast MRI.
    Schaefer AR; Yang L; Park JM; Xiong J; Fajardo LL
    Breast J; 2015; 21(4):395-402. PubMed ID: 25864435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.
    Pujara AC; Raad RA; Ponzo F; Wassong C; Babb JS; Moy L; Melsaether AN
    Breast J; 2016 May; 22(3):264-73. PubMed ID: 26843433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
    Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
    Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Analysis of Sternal Lesions Detected on Breast MRI in Patients Without History of Cancer.
    Jen A; Kochkodan-Self J; Mandell JC
    J Breast Imaging; 2023 Feb; 5(1):48-55. PubMed ID: 38416958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osseous metastases of chordoma: imaging and clinical findings.
    Chang C; Chebib I; Torriani M; Bredella M
    Skeletal Radiol; 2017 Mar; 46(3):351-358. PubMed ID: 28064345
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL
    Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography].
    Mende U; Huober J; Schmid H; Winterbauer T; Bastert G; Wannenmacher M
    Radiologe; 1996 Jan; 36(1):22-30. PubMed ID: 8820368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.
    Haraldsen A; Bluhme H; Røhl L; Pedersen EM; Jensen AB; Hansen EB; Nellemann H; Rasmussen F; Morsing A
    Clin Physiol Funct Imaging; 2016 Jan; 36(1):40-6. PubMed ID: 25257661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
    Jacobs MA; Macura KJ; Zaheer A; Antonarakis ES; Stearns V; Wolff AC; Feiweier T; Kamel IR; Wahl RL; Pan L
    Acad Radiol; 2018 Nov; 25(11):1405-1414. PubMed ID: 29627288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
    Dashevsky BZ; Goldman DA; Parsons M; Gönen M; Corben AD; Jochelson MS; Hudis CA; Morrow M; Ulaner GA
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1666-1673. PubMed ID: 25971426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients.
    Catalano OA; Nicolai E; Rosen BR; Luongo A; Catalano M; Iannace C; Guimaraes A; Vangel MG; Mahmood U; Soricelli A; Salvatore M
    Br J Cancer; 2015 Apr; 112(9):1452-60. PubMed ID: 25871331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.
    Garcia-Velloso MJ; Ribelles MJ; Rodriguez M; Fernandez-Montero A; Sancho L; Prieto E; Santisteban M; Rodriguez-Spiteri N; Idoate MA; Martinez-Regueira F; Elizalde A; Pina LJ
    Eur Radiol; 2017 Aug; 27(8):3190-3198. PubMed ID: 28004161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long disease-free survival following total sternal resection and reconstruction of the sternum with acrylic cement for unique massive sternal metastasis after operated breast cancer.
    Demetrian AD; Olteanu M; Mîndrilă I; Macovei A; Râmboiu DS; Enache ME; Bălă VS; Demetrian C; Popescu M; Streba CT
    Rom J Morphol Embryol; 2018; 59(4):1225-1232. PubMed ID: 30845305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sternal or parasternal involvement from breast cancer: a misleading clinical sign.
    Maalej M; Hentati D; Afrit M; Boudabous H; Nasr C; Mahjoubi K; Gargouri W
    Tunis Med; 2013 Jan; 91(1):54-8. PubMed ID: 23404599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone scintigraphy in patients with breast cancer: malignant involvement of the sternum.
    Ohtake E; Murata H; Maruno H
    Radiat Med; 1994; 12(1):25-8. PubMed ID: 8016400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer.
    Abikhzer G; Srour S; Fried G; Drumea K; Kozlener E; Frenkel A; Israel O; Fogelman I; Kagna O
    Nucl Med Commun; 2016 Nov; 37(11):1160-8. PubMed ID: 27536906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.